vs
百济神州（ONC）与Sunrun Inc.（RUN）财务数据对比。点击上方公司名可切换其他公司
百济神州的季度营收约是Sunrun Inc.的1.3倍（$1.5B vs $1.2B），Sunrun Inc.净利率更高（8.9% vs 4.4%，领先4.5%），Sunrun Inc.同比增速更快（123.5% vs 32.8%），过去两年Sunrun Inc.的营收复合增速更高（59.0% vs 41.2%）
BeOne Medicines（原百济神州）是一家跨国肿瘤领域制药企业，专注于癌症治疗创新药物的研发与商业化，致力于为全球癌症患者提供更有效、可及性更高的治疗方案，改善患者的生存质量与预后。
Sunrun Inc.是美国知名的光伏系统及电池储能产品供应商，业务以服务住宅客户为主，2007年成立，总部位于加利福尼亚州旧金山，致力于为家庭用户提供高效的清洁能源解决方案。
ONC vs RUN — 直观对比
营收规模更大
ONC
是对方的1.3倍
$1.2B
营收增速更快
RUN
高出90.7%
32.8%
净利率更高
RUN
高出4.5%
4.4%
两年增速更快
RUN
近两年复合增速
41.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.2B |
| 净利润 | $66.5M | $103.6M |
| 毛利率 | 90.5% | — |
| 营业利润率 | 12.4% | 8.4% |
| 净利率 | 4.4% | 8.9% |
| 营收同比 | 32.8% | 123.5% |
| 净利润同比 | 143.8% | 103.7% |
| 每股收益（稀释后） | $0.05 | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ONCRUN
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.4B | $724.6M | ||
| Q2 25 | $1.3B | $569.3M | ||
| Q1 25 | $1.1B | $504.3M | ||
| Q4 24 | $1.1B | $518.5M | ||
| Q3 24 | $1.0B | $537.2M | ||
| Q2 24 | $929.2M | $523.9M | ||
| Q1 24 | $751.7M | $458.2M |
净利润ONCRUN
| Q4 25 | $66.5M | $103.6M | ||
| Q3 25 | $124.8M | $16.6M | ||
| Q2 25 | $94.3M | $279.8M | ||
| Q1 25 | $1.3M | $50.0M | ||
| Q4 24 | $-151.9M | $-2.8B | ||
| Q3 24 | $-121.3M | $-83.8M | ||
| Q2 24 | $-120.4M | $139.1M | ||
| Q1 24 | $-251.2M | $-87.8M |
毛利率ONCRUN
| Q4 25 | 90.5% | — | ||
| Q3 25 | 86.1% | — | ||
| Q2 25 | 87.5% | — | ||
| Q1 25 | 85.2% | — | ||
| Q4 24 | 85.8% | — | ||
| Q3 24 | 83.0% | — | ||
| Q2 24 | 85.1% | — | ||
| Q1 24 | 83.4% | — |
营业利润率ONCRUN
| Q4 25 | 12.4% | 8.4% | ||
| Q3 25 | 11.5% | 0.5% | ||
| Q2 25 | 6.7% | -19.7% | ||
| Q1 25 | 1.0% | -22.8% | ||
| Q4 24 | -7.0% | -628.0% | ||
| Q3 24 | -12.0% | -23.8% | ||
| Q2 24 | -11.5% | -24.4% | ||
| Q1 24 | -34.8% | -40.0% |
净利率ONCRUN
| Q4 25 | 4.4% | 8.9% | ||
| Q3 25 | 8.8% | 2.3% | ||
| Q2 25 | 7.2% | 49.1% | ||
| Q1 25 | 0.1% | 9.9% | ||
| Q4 24 | -13.5% | -542.7% | ||
| Q3 24 | -12.1% | -15.6% | ||
| Q2 24 | -13.0% | 26.5% | ||
| Q1 24 | -33.4% | -19.2% |
每股收益（稀释后）ONCRUN
| Q4 25 | $0.05 | $0.38 | ||
| Q3 25 | $0.08 | $0.06 | ||
| Q2 25 | $0.06 | $1.07 | ||
| Q1 25 | $0.00 | $0.20 | ||
| Q4 24 | $-0.10 | $-12.59 | ||
| Q3 24 | $-0.09 | $-0.37 | ||
| Q2 24 | $-0.09 | $0.55 | ||
| Q1 24 | $-0.19 | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | — |
| 总债务越低越好 | $836.4M | $14.7B |
| 股东权益账面价值 | $4.4B | $3.1B |
| 总资产 | $8.2B | $22.6B |
| 负债/权益比越低杠杆越低 | 0.19× | 4.69× |
8季度趋势，按日历期对齐
现金及短期投资ONCRUN
| Q4 25 | $4.5B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $2.8B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.7B | — | ||
| Q2 24 | $2.6B | — | ||
| Q1 24 | $2.8B | — |
总债务ONCRUN
| Q4 25 | $836.4M | $14.7B | ||
| Q3 25 | — | $14.6B | ||
| Q2 25 | — | $14.0B | ||
| Q1 25 | — | $13.6B | ||
| Q4 24 | — | $12.9B | ||
| Q3 24 | — | $12.5B | ||
| Q2 24 | — | $12.0B | ||
| Q1 24 | — | $11.1B |
股东权益ONCRUN
| Q4 25 | $4.4B | $3.1B | ||
| Q3 25 | $4.1B | $3.0B | ||
| Q2 25 | $3.8B | $2.9B | ||
| Q1 25 | $3.5B | $2.6B | ||
| Q4 24 | $3.3B | $2.6B | ||
| Q3 24 | $3.4B | $5.3B | ||
| Q2 24 | $3.4B | $5.4B | ||
| Q1 24 | $3.4B | $5.2B |
总资产ONCRUN
| Q4 25 | $8.2B | $22.6B | ||
| Q3 25 | $7.6B | $22.2B | ||
| Q2 25 | $6.3B | $21.2B | ||
| Q1 25 | $5.8B | $20.4B | ||
| Q4 24 | $5.9B | $19.9B | ||
| Q3 24 | $5.8B | $22.1B | ||
| Q2 24 | $5.7B | $21.4B | ||
| Q1 24 | $5.7B | $20.8B |
负债/权益比ONCRUN
| Q4 25 | 0.19× | 4.69× | ||
| Q3 25 | — | 4.90× | ||
| Q2 25 | — | 4.80× | ||
| Q1 25 | — | 5.19× | ||
| Q4 24 | — | 5.05× | ||
| Q3 24 | — | 2.36× | ||
| Q2 24 | — | 2.23× | ||
| Q1 24 | — | 2.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $417.3M | $96.9M |
| 自由现金流经营现金流 - 资本支出 | $379.8M | — |
| 自由现金流率自由现金流/营收 | 25.4% | — |
| 资本支出强度资本支出/营收 | 2.5% | — |
| 现金转化率经营现金流/净利润 | 6.28× | 0.94× |
| 过去12个月自由现金流最近4个季度 | $941.7M | — |
8季度趋势，按日历期对齐
经营现金流ONCRUN
| Q4 25 | $417.3M | $96.9M | ||
| Q3 25 | $402.6M | $-121.5M | ||
| Q2 25 | $263.6M | $-292.7M | ||
| Q1 25 | $44.1M | $-104.2M | ||
| Q4 24 | $75.2M | $-258.4M | ||
| Q3 24 | $188.4M | $-156.2M | ||
| Q2 24 | $-95.6M | $-208.5M | ||
| Q1 24 | $-308.6M | $-143.1M |
自由现金流ONCRUN
| Q4 25 | $379.8M | — | ||
| Q3 25 | $354.5M | — | ||
| Q2 25 | $219.8M | — | ||
| Q1 25 | $-12.3M | — | ||
| Q4 24 | $-17.3M | — | ||
| Q3 24 | $54.7M | $-156.4M | ||
| Q2 24 | $-205.5M | — | ||
| Q1 24 | $-465.1M | — |
自由现金流率ONCRUN
| Q4 25 | 25.4% | — | ||
| Q3 25 | 25.1% | — | ||
| Q2 25 | 16.7% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | -1.5% | — | ||
| Q3 24 | 5.5% | -29.1% | ||
| Q2 24 | -22.1% | — | ||
| Q1 24 | -61.9% | — |
资本支出强度ONCRUN
| Q4 25 | 2.5% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | 13.3% | 0.0% | ||
| Q2 24 | 11.8% | — | ||
| Q1 24 | 20.8% | — |
现金转化率ONCRUN
| Q4 25 | 6.28× | 0.94× | ||
| Q3 25 | 3.22× | -7.33× | ||
| Q2 25 | 2.79× | -1.05× | ||
| Q1 25 | 34.71× | -2.08× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.50× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ONC
暂无分部数据
RUN
| Products | $692.3M | 60% |
| Customer Agreements | $435.2M | 38% |
| Manufactured Product Other | $56.7M | 5% |
| Incentives | $31.3M | 3% |
